T2 Biosystems Inc (T2) is an in vitro diagnostics company. It offers T2Dx instrument, T2 bacteria panel, T2 candida panel, T2 SARS - CoV-2 panel and T2MR technology. Its pipeline includes T2 resistance panel, T2 lyme panel, T2 cauris panel and T2 biothreat panel. T2 resistance panel is designed for the direct from blood detection of antibiotic resistance genes associated with sepsis causing pathogens. T2 lyme panel identifies borrelia burgdorferi, the bacteria that is the most common cause of lyme disease. T2 is headquartered in Lexington, Massachusetts, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company T2 Biosystems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- T2 Biosystems Inc Company Overview
- T2 Biosystems Inc Company Snapshot
- T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
- T2 Biosystems Inc - Pipeline Analysis Overview
- T2 Biosystems Inc - Key Facts
- T2 Biosystems Inc - Major Products and Services
- T2 Biosystems Inc Pipeline Products by Development Stage
- T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
- T2 Biosystems Inc Pipeline Products Overview
- Comprehensive Sepsis Panel
- Comprehensive Sepsis Panel Product Overview
- Monkeypox Molecular Diagnostic Test Kit
- Monkeypox Molecular Diagnostic Test Kit Product Overview
- Next Generation T2Dx Instrument
- Next Generation T2Dx Instrument Product Overview
- T2Bacteria Panel
- T2Bacteria Panel Product Overview
- T2Candida Panel
- T2Candida Panel Product Overview
- T2Candida Panel Clinical Trial
- T2Candida Panel - Pediatric Testing
- T2Candida Panel - Pediatric Testing Product Overview
- T2Carba Resistance
- T2Carba Resistance Product Overview
- T2Cauris Panel
- T2Cauris Panel Product Overview
- T2Dx - Cancer
- T2Dx - Cancer Product Overview
- T2Dx - Cardiac
- T2Dx - Cardiac Product Overview
- T2Dx Instrument
- T2Dx Instrument Product Overview
- T2Endotoxin
- T2Endotoxin Product Overview
- T2HemoStat
- T2HemoStat Product Overview
- T2Lyme Panel
- T2Lyme Panel Product Overview
- T2MR Assay - Platelet Function Testing
- T2MR Assay - Platelet Function Testing Product Overview
- T2Plex
- T2Plex Product Overview
- T2Resistance Panel
- T2Resistance Panel Product Overview
- T2Resistance Panel Clinical Trial
- T2Resistance Panel - Expansion
- T2Resistance Panel - Expansion Product Overview
- T2 Biosystems Inc - Key Competitors
- T2 Biosystems Inc - Key Employees
- T2 Biosystems Inc - Key Employee Biographies
- T2 Biosystems Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- T2 Biosystems Inc, Recent Developments
- Jul 29, 2024: T2 Biosystems Announces Commercial Expansion Through Malaysia and Indonesia Distributor
- Jun 25, 2024: T2 Biosystems Announces Commercial Expansion Through Hong Kong and Macau Distributor
- May 06, 2024: T2 Biosystems Announces Letter of Intent to Enter Strategic Partnership for Lyme Disease
- May 06, 2024: T2 Biosystems Announces Commercial Expansion Through Middle East Distributor
- Mar 28, 2024: T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient
- Mar 20, 2024: T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
- Mar 19, 2024: T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates
- Mar 18, 2024: T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
- Feb 12, 2024: T2 Biosystems Receives FDA 510(k) Clearance for the Expanded T2Bacteria Panel
- Feb 07, 2024: U.S. Department of Health and Human Services and Steven and Alexandra Cohen Foundation Name T2 Biosystems a Phase 2 Winner in the LymeX Diagnostics Prize
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview
- T2 Biosystems Inc Pipeline Products by Equipment Type
- T2 Biosystems Inc Pipeline Products by Indication
- T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
- T2 Biosystems Inc, Key Facts
- T2 Biosystems Inc, Major Products and Services
- T2 Biosystems Inc Number of Pipeline Products by Development Stage
- T2 Biosystems Inc Pipeline Products Summary by Development Stage
- T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
- T2 Biosystems Inc Ongoing Clinical Trials Summary
- Comprehensive Sepsis Panel - Product Status
- Comprehensive Sepsis Panel - Product Description
- Monkeypox Molecular Diagnostic Test Kit - Product Status
- Monkeypox Molecular Diagnostic Test Kit - Product Description
- Next Generation T2Dx Instrument - Product Status
- Next Generation T2Dx Instrument - Product Description
- T2Bacteria Panel - Product Status
- T2Bacteria Panel - Product Description
- T2Candida Panel - Product Status
- T2Candida Panel - Product Description
- T2Candida Panel - Invasive Candidiasis in Critical Care
- T2Candida Panel - Pediatric Testing - Product Status
- T2Candida Panel - Pediatric Testing - Product Description
- T2Carba Resistance - Product Status
- T2Carba Resistance - Product Description
- T2Cauris Panel - Product Status
- T2Cauris Panel - Product Description
- T2Dx - Cancer - Product Status
- T2Dx - Cancer - Product Description
- T2Dx - Cardiac - Product Status
- T2Dx - Cardiac - Product Description
- T2Dx Instrument - Product Status
- T2Dx Instrument - Product Description
- T2Endotoxin - Product Status
- T2Endotoxin - Product Description
- T2HemoStat - Product Status
- T2HemoStat - Product Description
- T2Lyme Panel - Product Status
- T2Lyme Panel - Product Description
- T2MR Assay - Platelet Function Testing - Product Status
- T2MR Assay - Platelet Function Testing - Product Description
- T2Plex - Product Status
- T2Plex - Product Description
- T2Resistance Panel - Product Status
- T2Resistance Panel - Product Description
- T2Resistance Panel - T2Resistance 510(k) Study Protocol - Detection and Identification of Several Classes of Resistance Genes in Both Gram-positive and Gram-negative Pathogens
- T2Resistance Panel - Expansion - Product Status
- T2Resistance Panel - Expansion - Product Description
- T2 Biosystems Inc, Key Employees
- T2 Biosystems Inc, Key Employee Biographies
- T2 Biosystems Inc, Other Locations
- T2 Biosystems Inc, Subsidiaries
- Glossary
- T2 Biosystems Inc Pipeline Products by Equipment Type
- T2 Biosystems Inc Pipeline Products by Development Stage
- T2 Biosystems Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- BioFire Diagnostics Inc
- GenMark Diagnostics Inc
- Becton Dickinson and Co
- Celula Inc
- OpGen Inc
